Cancer Chemoprevention: Progress and Promise
Open Access
- 21 October 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 90 (20), 1514-1528
- https://doi.org/10.1093/jnci/90.20.1514
Abstract
In the relatively brief history of cancer chemoprevention, hundreds of chemoprevention studies have been reported. The vast majority were uncontrolled studies that were designed and reported in a nonrigorous fashion, which perhaps resulted largely from the zealousness of early chemoprevention researchers to nurture growth of an exciting novel approach through its infancy. Nevertheless, limitations characterizing many of these trials have tended to cloud chemoprevention's record of progress and promise. This tendency overlooks the solid cohort of definitive randomized trials that have successfully addressed many important clinical questions.Keywords
This publication has 81 references indexed in Scilit:
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Plant-derived anticancer agentsBiochemical Pharmacology, 1997
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995
- Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized TrialJNCI Journal of the National Cancer Institute, 1993
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986